A promising cancer drug that's being developed based on a discovery by our Kimberly Kelly, PhD, is attracting major interest -- to the tune of $25 million.
When our David Kashatus, PhD, was first interviewing here in 2012, he laid out an ambitious research project that would help us better understand pancreatic cancer. Seven years later, he has completed that work and given us important new insights into how the aggressive cancer fuels its growth.
Young scientists from Brazil have joined the School of Medicine this semester as part of a new exchange program. One tells us what it's like coming to America.
The Integrated Translational Health Research Institute of Virginia (iTHRIV), which aims to improve the health of people across the state and beyond, this week spotlighted clinical research findings from the last year. The work was impressive.
The eyeball keeps it shape because of the liquid inside. What's the deal?
More than 20 percent of University of Virginia students reported vaping in the previous month.
